z-logo
open-access-imgOpen Access
The effect of anti TNF alpha (certolizumab) treatment on insulin resistance, lipid parameters and cardiovascular risk in patients with axial spondyloarthritis (ankylosing spondylitis)
Author(s) -
Hasan Göğebakan,
Gözde Yıldırım Çetin
Publication year - 2022
Publication title -
dahuder medical journal
Language(s) - English
Resource type - Journals
ISSN - 2791-9250
DOI - 10.56016/dahudermj.1146178
Subject(s) - medicine , insulin resistance , quantitative insulin sensitivity check index , framingham risk score , insulin , endocrinology , gastroenterology , lipid profile , spondylitis , ankylosing spondylitis , cholesterol , disease , insulin sensitivity

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom